期刊文献+

高敏肌钙蛋白升高的临床意义 被引量:8

The clinical implications of elevated high-sensitive cardiac troponin
原文传递
导出
摘要 2009年“高敏感肌钙蛋白”检测试剂投入国内临床应用,2012年国际上又有几种高敏感试剂陆续投入临床应用,且正在进行我国食品药物管理局的报批.高敏肌钙蛋白由于检测敏感性的提高,使得对急性冠脉综合征诊断时间窗提前2~3 h,同时使对心肌损伤的检测范围与前一代试剂相比有了极大的扩展.正是由于涉及范围的扩大给临床带来许多“困惑”.在用的还没“消化”,又有新的即将进来,我们准备好了吗?我们能否像美国那样在食品和药物管理局正式批准前,检验与临床加强学习,加强沟通与交流,形成共识. The new generation "high-sensitivity cardiac troponin" assays have been used in clinic for nearly 5 years in China. In 2012, several new high-sensitivity assays have been approved to be used in clinic in other countries, and they are under inspection of Chinese Food and Drug Ddministration. Because the new generation assays' sensitivity is improved, acute coronary syndrome could have been diagnosed 2-3 hours earlier, and small cardiac injuries that could not be detected by previous assays are detectable now. But its advantages also bring challenges to doctors. Many doctors can't even use previous assays well. The clinical doctors and laloiatory stuffs need to comunicate and reach a consensus just like American doctors do before American food and drug administration approve it.
作者 张真路 周新
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2014年第7期555-558,共4页 Chinese Journal of Laboratory Medicine
关键词 肌钙蛋白 敏感性与特异性 心肌梗死 Troponin Sensitivity and specificity Myocardial infarction
  • 相关文献

参考文献17

  • 1Newby LK, Jesse RL, Babb JD, et al. ACCF 2012 expertconsensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American Cgllege of Cardiology Foundation task force on Clinical Expert Consensus Documents[J]. J Am Coil Cardiol, 2012, 60: 2427- 2463.
  • 2Korley FK, Jaffe AS. Preparing the United States for high- sensitivity cardiac troponin assays[J]. J Am Coil Cardiol, 2013, 61 : 1753-1758.
  • 3张真路.如何面对新一代高敏感肌钙蛋白检测时代的到来[J].中华检验医学杂志,2012,35(12):1081-1086. 被引量:3
  • 4Apple FS, Collinson PO. Analytical characteristics of high- sensitivity cardiac troponin assays [ J]. Clin Chem, 2012, 58: 54-61.
  • 5Jaffe AS. The 10 commandments of troponin, with special reference to high sensitivity assays[J]. Heart, 2011, 97: 940- 946.
  • 6Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction[J]. Eur Heart J, 2012, 33 : 2551-2567.
  • 7Apple FS, Murakami MM. Serum and plasma cardiac troponin I 99th percentile reference values for 3 2nd-generation assays [ J ]. Cliu Chem, 2007, 53 : 1558-1560.
  • 8Collinson PO, Clifford-Mobley O, Gaze D, et al. Assay imprecision and 99th-percentile reference value of a high- sensitivity cardiac troponin I assay[J]. Clin Chem, 2009, 55 : 1433-1434.
  • 9de Lemos JA. Increasingly sensitive assays for cardiac troponins : a review[J]. JAMA, 2013, 309: 2262-2269.
  • 10Genna Rollins. New, Practical Guidance for Cardiac Troponin. How Can Laboratorians Help Physicians? [ J]. Clinical Laboratory News, 2013, 39: 2.

二级参考文献41

  • 1Thygesen K,Alpert JS,White HD. Universal definition of myocardial infarction[J].Circulation,2007,(22):2634-2653.doi:10.1161/CIRCULATIONAHA.107.187397.
  • 2Wright RS,Anderson JL,Adams CD. 2011 ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline):a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American College of Emergency Physicians,Society for Cardiovascular Angiograp[J].Journal of the American College of Cardiology,2011.1920-1959.
  • 3Jaffe AS,Babuin L,Apple FS. Biomarkers in acute cardiac disease:the present and the future[J].Journal of the American College of Cardiology,2006.1-11.
  • 4Friess U,Stark M. Cardiac markers:a clear cause for point-of-care testing[J].Analytical Biochemistry,2009.1453-1462.
  • 5Apple FS,Jesse RL,Newby LK. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines:Analytical issues for biochemical markers of acute coronary syndromes[J].Circulation,2007.e352-e355.
  • 6Pulkki K,Suvisaari J,Collinson P. A pilot survey of the use and implementation of cardiac markers in acute coronary syndrome and heart failure across Europe.The CARdiac MArker Guideline Uptake in Europe (CARMAGUE) study[J].Clinical Chemistry and Laboratory Medicine,2009.227-234.
  • 7Cardinale D,Colombo A,Torrisi R. Trastuzumab-induced cardiotoxicity:clinical and prognostic implications of troponin Ⅰ evaluation[J].Journal of Clinical Oncology,2010.3910-3916.
  • 8Scirica BM. Acute coronary syndrome:emerging tools for diagnosis and risk assessment[J].Journal of the American College of Cardiology,2010.1403-1415.
  • 9Wu AH,Lu QA,Todd J. Short-and long-term biological variation in cardiac troponin Ⅰ measured with a high-sensitivity assay:implications for clinical practice[J].Clinical Chemistry,2009.52-58.
  • 10Jaffe AS,Apple FS. High-sensitivity cardiac troponin:hype,help,and reality[J].Clinical Chemistry,2010.342-344.

共引文献2

同被引文献46

  • 1申华,周玉杰.2011欧洲心脏病学会非ST段抬高型急性冠脉综合征处理指南更新解读[J].中国医学前沿杂志(电子版),2011,3(5):97-99. 被引量:20
  • 2Shi Y,Gong HL,Zhou L,et al.Diekkopf-1 is a novel prog- nostic biomarker for laryngeal squamous cell carcinoma[J]. Acta Otolaryngol, 2014,134 (7) : 753-759.
  • 3Begenik H,Kemik A,Emre H,et al.The association between serum Dickkopf-1 levels and esophageal squamous cell carcinoma[J].Hum Exp Toxicol, 2014,33 (8) : 785-788.
  • 4Sang Y,Cheng C,Tang XF,et al.Hypermethylation of TET1 promoter is a new diagnosic marker for breast cancer metastasis[J].Asian Pac J Cancer Prew,2015,16(3) : 1197- 1200.
  • 5Barriere G, Fici P, Gallerani G,et al.Circulating tumor cells and epithelial,mesenchymal and sternness markers:charac- terization of cell subpopulations[J].Ann Transl Med, 2014, 2(11):109.
  • 6Ye HM, Lu YZ, Liang XM,et al.Clinical significance of com- bined testing of YKL-40 with CEA in Chinese colorectal cancer patients[J].Clin Lab, 2014,60(3) : 397-405.
  • 7Moura RS, Carvalho-Correia E,Damota P,et al.Canonical Wnt signaling activity in early stages of chick lung devel- opment[J].PLos One, 2014,9(12) : el 12388.
  • 8Liu K,Luo Y,Tian H,et al.The tumor suppressor LKB1 antagonizes WNT signaling pathway through modulating GSK313 activity in cell growth of esophageal carcinoma[J]. Tumour B iol, 2014,35 (2) : 995-1002.
  • 9Kariagina A, Xie J, Langohr IM,et al.Progesterone decreas- es levels of the adhesion protein E-cadherin and promotes invasiveness of steroid receptor positive breast cancers[J]. Horm Cancer,2013,4(6) : 371-380.
  • 10Hou L,Wang X,Zhou Y,et al.Inhibitory effect and mech- anism of mesenchymal stem ceils on liver cancer cells[J]. Tumour Biol, 2014,35 (2) : 1239-1250.

引证文献8

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部